At NegotiumBio, we support global pharma and biotech companies to develop and implement their outsourcing strategy across any drug modality. Our team is experienced in completing complex business transactions across a wide diversity of drug modalities including cellular and gene therapies (CAR-T, TCR, CRISPR, viral vector, autologous / allogenic supply chains, stem cell), biologics (mAB, protein, etc.), and small molecules.
We help you to qualify, choose and manage your suppliers applying a systematic diligence process. This allows you to mitigate the risks commonly associated with outsourced manufacturing, regardless of your location. In addition, we provide guidance for developing raw material (GMP and non-GMP) management programs through either direct OEM or consolidation strategies enabled with the latest digital cataloging and/or marketplace cloud tools.
RESEARCH: We scan the market to help you to make informed outsourcing decisions.
MODELLING: We infer the costs to manufacture your product through our deep understanding of technical operations and the materials markets.
RISK ASSESSMENT: We evaluate your supply chain holistically to identify both macro and micro risks.
DUE DILIGENCE: We help you ensure a well-documented and thorough supplier qualification process to meet cGMP requirements.
NEGOTIATE: We work with your scientists and development teams to better position them at the negotiation table
MANAGE: We are happy to continue to manage the supplier relationship and support your subsequent project management needs.
CONTACT US:
NegotiumBio, LLC, North Andover, USA
NegotiumBio GmbH, Basel, Switzerland
inquiries@negotiumbio.com
Company Details
- Employees
- 6
- Founded
- -
- Address
- North Andover, Ma 01845, Us
- Industry
- Biotechnology
- Website
- http://www.negotiumbio.com
- Keywords
- outsourcing, procurement, supply chain, risk analysis, CMO, custom manufacturing, CMC, CAR-T, API, pharmaceutical, cell & gene, small molecules, large molecules, technology management, start up, investment, biologics, OEM, CRISPR, viral vector.
- HQ
- North Andover, MA
Negotiumbio Questions
Negotiumbio's website is http://www.negotiumbio.com
Negotiumbio's LinkedIn profile is https://www.linkedin.com/company/negotiumbio
Negotiumbio has
6 employees.
View email and phone details for 6
employees at Negotiumbio.
Negotiumbio's industry is
Biotechnology
Negotiumbio's top competitors are
Naerobix,
Negotiumai,
Allotrope Cgmp Consulting,
Supplyfirst,
Protevobio, Inc.,
Si Group,
Catalent,
Cellestia Biotech,
Drug Discovery Alliances, Inc.,
Rivera Corps Llc.
Negotiumbio's categories are Biotechnology
Negotiumbio's founding year is 2018
